| |
Novartis AG (ADR) |
This post is nine hours old and no one has responded to it because
what can anyone advise? Drug companies are tough to time because of
approvals, acquisitions, generics, etc. I guess you will have to
decide if you want this position as an investment or a trade. As an
investment it will likely do very well as a hold given enough time. As
a trade, the next six months are probably going to be flat so your
money would do best elsewhere. But remember, these companies can
change on a dime with M&As. Good luck.